Effects of glucocorticoid on cardiac chronotropic responsiveness in cirrhotic rats: A possible role for dopamine receptors

Document Type : Original Article

Authors

1 Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA

4 Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences, Lahore, Pakistan

5 Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, USA

10.22038/ijbms.2026.91247.19739

Abstract

Objective(s): Cirrhosis causes chronotropic dysfunction by weakening the β-adrenergic receptor (β-AR) signaling pathway in cirrhotic cardiomyopathy (CCM). Downstream signaling of glucocorticoids and dopamine receptors influences the β-AR pathway. Thus, the effects of glucocorticoids on chronotropic incompetence and the possible involved pathways were investigated in this experiment. 
Materials and Methods: Bile duct ligation (BDL) surgery was performed on Wistar rats to induce cirrhosis. Four weeks after BDL or sham surgery, the subjects were given an intramuscular injection of either saline (NS) or dexamethasone (dexa)  (2.2 mg/kg/day) for three consecutive days. In vivo, chronotropic responsiveness to isoproterenol and QTc interval were evaluated by electrocardiogram (ECG). Real-time polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC) were performed to determine the effectiveness of dexa on dopamine D1, D2 receptors, and GNAL mRNA expression. Moreover, the tumor necrosis factor-alpha (TNF-α) and interleukin‐1beta (IL-1β) levels in rats’ hearts were assessed.
Results: Dexa treatment reduced the prolonged QT intervals in cirrhosis. It also dedcreasd spleen weight, as well as TNF-α levels, which are increased in cirrhosis. Moreover, dexa increased D1 protein expression in IHC. 
Conclusion: Dexa effectively improved cirrotic heart by improving QT intervales and increasing spleen weight,  reducing a pro-inflammatory cytokine, and up-regulateing  D1 receptor protein expression. 

Keywords

Main Subjects


1. Ma Z. Lee SS. Cirrhotic cardiomyopathy: Getting to the heart of the matter. Hepatology 1996; 24: 451-459.
2. Møller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010; 53: 179-190.
3. Harrell C, Gillespie C, Neigh G. Energetic stress: The reciprocal relationship between energy availability and the stress response. Physiol Behav 2016; 166: 43-55.
4. Kelley C, Molen JV, Choi J, Bhai S,  Martin K , Cochran C, et al. Impact of glucocorticoids on cardiovascular system—the yin yang effect. J Pers Med 2022; 12: 1829.
5. Trucco SM, Jaeggi E, Cuneo B, Moon-Grady AJ, Silverman E, Silverman N, et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol 2011; 57: 715-723.
6. Halonen J, Halonen P, Järvinen O, Taskinen P,  Auvinen T,  Tarkka M,  et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial. Randomized Controlled Trial JAMA 2007; 297: 1562-1567.
7. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000; 21: 55-89.
8. Czyrak A, Maćkowiak M, Chocyk A, Fijał K, Wedzony K, et al. Role of glucocorticoids in the regulation of dopaminergic neurotransmission. Pol J Pharmacol 2003; 55: 667-674.
9. Sigala S, Missale C, Tognazzi N, Spano P. Differential gene expression of dopamine D-2 receptor subtypes in rat chromaffin cells and sympathetic neurons in culture. Neuroreport 2000; 11: 2467-2471.
10. Missale C, Nash SR, Robinson Sw, Jaber M, Caron MG. Dopamine receptors: From structure to function. Physiol Rev 1998; 78:189-225.
11. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. New Engl J Med 1991; 325: 625-632.
12. Nguyen AM, Semeano A , Quach V, Inoue A, Nichols DE, Yano H. Characterization of Gαs and Gαolf activation by catechol and non-catechol dopamine D1 receptor agonists. iScience 2025;28:112345. 
13. Kaur G, Kumar Verma Sh, Singh D, Singh NK, et al. Role of G-proteins and GPCRs in cardiovascular pathologies. Bioengineering 2023; 10: 76.
14. Alcacer C, Santini E , Valjent E, Gaven F, Girault JA, Hervé D, et al. Gαolf mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3, 4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci 2012; 32: 5900-5910.
15. Zhuang X, Belluscio L, Hen R. Golfα mediates dopamine D1 receptor signaling. J Neurosci 2000; 20:  RC91-RC91.
16. Corvol J, Studler JM, Schonn JS, Girault JA, Hervé D, et al. Gαolf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J Neurochem 2001; 76: 1585-1588.
17. Missale C, Pizzi M, Memo M, Picotti GB, Carruba MO, Spano PF, et al. Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries. Neurosci Lett 1985; 61: 207-211.
18.    Khalil B, Rosani A, Warrington SJ. Physiology, Catecholamines. In: StatPearls (Internet). 2024; StatPearls Publishing.
19.    Yang YY, Lin HC. The heart: Pathophysiology and clinical implications of cirrhotic cardiomyopathy. J Chin Med Assoc 2012; 75: 619-623.
20.    Sucharov CC. β-adrenergic pathways in human heart failure. Expert Rev Cardiovasc Ther 2007; 5: 119-124.
21.    Liu SH, Lin FJ, Kao YH, Chen PH, Lin YK , Lu YY et al. Chronic partial sleep deprivation increased the incidence of atrial fibrillation by promoting pulmonary vein and atrial arrhythmogenesis in a rodent model. Int J Mol Sci 2024; 25: 7619.
22. Jazaeri F, Tavangar SM, Ghazi-Khansari M, Khorramizadeh MR, Mani AR, Dehpour AR, et al. Cirrhosis is associated with development of tolerance to cardiac chronotropic effect of endotoxin in rats. Liver Int 2013; 33: 368-374.
23. Zepeda-Morales ASM, Toro-Arreola SD, García-Benavides L, Bastidas-Ramírez BE, Fafutis-Morris M, Pereira-Suárez AL,  et al. Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression. Ann Hepatol 2016; 15: 418-426.
24.    Earp JC, Pyszczynski NA, Molano DS, Jusko WJ. Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis. Biopharm Drug Dispos 2008; 29: 366-372.
25. Nguyen TT, Almon RR, Dubois DC, Jusko WJ, Androulakis IP. Comparative analysis of acute and chronic corticosteroid pharmacogenomic effects in rat liver: Transcriptional dynamics and regulatory structures. BMC Bioinformatics  2010; 11: 515.
26. Williams DM. Clinical pharmacology of corticosteroids. Respir Care 2018; 63: 655-670.
27. Esmaeili Z, Niaz Q, Mirzaee Saffari P, Dehpour AR, Rezayat SM, et al. Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats. Life Sci 2021;273: 119261.
28. Uhlig M, Hein M, Habigt MA, Tolba RH , Braunschweig T, Helmedag MJ et al. Cirrhotic Cardiomyopathy Following Bile Duct Ligation in Rats—A Matter of Time? Int J Mol Sci 2023; 24: 8147.
29. Valeeva EV, Semina II, Galeeva AG, Mukhametshina AD, Mukhametshina RD et al., Effect of chronic stress on the relative level of dopamine receptor gene expression. Kazan Med J 2022; 103: 418-426.
30. Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis 2002; 34: 144-150.
31. Milani A,  Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathy. Dig Liver Dis  2007; 39: 507-515.
32. Bernardi M, Calandra S, Colantoni A, Trevisani F, Raimondo ML, Sica G, Schepis F, et al. Q‐T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998; 27: 28-34.
33. Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Pieruzzi F, et al. QT interval prolongation and decreased heart rate variability in cirrhotic patients: Relevance of hepatic venous pressure gradient and serum calcium. Clin Sci (Lond) 2009; 116: 851-859.
34. Hennis K, Piantoni Ch, Biel M, Fenske S, Wahl-Schott Ch. Pacemaker channels and the chronotropic response in health and disease. Circ Res 2024; 134: 1348-1378.
35. Ryu DG, Yu F, Yoon KT, Liu H,  Lee  SS. The cardiomyocyte in cirrhosis: Pathogenic mechanisms underlying cirrhotic cardiomyopathy. Rev Cardiovasc Med 2024; 25: 457.
36. Cotecchia S, De Blasi A. Glucocorticoids increase β-adrenoceptors on human intact lymphocytes in vitro. Life Sci 1984; 35: 2359-2364.
37. Lee T, Reed CE. Effects of steroids on the regulation of the levels of cyclic AMP in human lymphocytes. Biochem Biophys Res Commun 1977; 78: 998-1004.
38. Sakurai K, Osada Y, Takeba Y, Mizuno M , Tsuzuki Y, Ohta  Y, et al. Exposure of immature rat heart to antenatal glucocorticoid results in cardiac proliferation. Pediatr Int 2019; 61: 31-42.
39. Kuropka P, Dobrzyński M, Gamian A, Gostomska-Pampuch K, Kuryszko J, et al. Effect of glucocorticoids on ultrastructure of myocardial muscle in the course of experimentally induced acute myocardial ischemia. Biomed Res Int 2017; 2017: 2108497.
40. Motta K, Gomes PRL, Sulis PM, Bordin S, Rafacho A. Dexamethasone administration during late gestation has no major impact on lipid metabolism, but reduces newborn survival rate in Wistar rats. Front Physiol 2018; 9: 783.
41. Gay MS, Li Y, Xiong F, Lin T, Zhang L. Dexamethasone treatment of newborn rats decreases cardiomyocyte endowment in the developing heart through epigenetic modifications. PLoS One 2015; 10:  e0125033.
42. Mannelli M, Pupilli C, Fabbri G, Musante R, De Feo ML, Franchi F, et al. Endogenous dopamine (DA) and DA2 receptors: A mechanism limiting excessive sympathetic-adrenal discharge in humans. J Clin Endocrinol Metab  1988; 66: 626-631.
43. Ward CA, Liu H, Lee SS. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy. Gastroenterology 2001; 121: 1209-1218.
44. Wang L, Cui Y, Liu Q , Song Y, Hu Q, Tang M, et al., Puerarin enhances Ca2+ reuptake and Ca2+ content of sarcoplasmic reticulum in murine embryonic stem cell-derived Cardiomyocytes via Upregulation of SERCA2a. Cell Physiol Biochem 2017; 44: 1199-1212.
45.    Surmeier DJ, Bargas J, Hemmings Jr HC, Nairn AC, Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 1995; 14: 385-397.
46.    Artalejo CR,  Ariano MA, Perlman RL, Fox AP. Activation of facilitation calcium channels in chromaffin cells by D 1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism. Nature 1990; 348: 239-242.
47. Tobón KE, Chang D, Kuzhikandathil EV. MicroRNA 142-3p mediates post-transcriptional regulation of D1 dopamine receptor expression. PLoS One 2012; 7: e49288.
48. Wu X, Xu FL, Xia X, Wang BJ, Yao J. MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3′ UTR–12 bp to+ 154 bp. Artif Cells Nanomed Biotechnol 2020; 48: 276-287.
49. Clayton SA, Jones SW, Kurowska-Stolarska M, Clark AR et al. The role of microRNAs in glucocorticoid action. J Biol Chem 2018; 293: 1865-1874.
50. Nibley PC, Shenoy SK. β-adrenergic receptor signaling mediated by β-arrestins and its potential role in heart failure. Curr Opin Physiol 2023; 37:100723.
51. Datsko V, Fedoniuk LY, Ivankiv YI, Kurylo KhI, Volska AS, Malanchuk SL, et al. Experimental cirrhosis: Liver morphology and function. Wiad Lek 2020; 73: 947-952.
52. Al Kury LT, Voitychuk OI, Ali RM, Galadari S, Yang KHS, Howarth FC, et al. Effects of endogenous cannabinoid anandamide on excitation–contraction coupling in rat ventricular myocytes. Cell Calcium 2014; 55: 104-118.
53. Yang YY, Liu H, Nam SW, Kunos G, Lee SS. Mechanisms of TNFα-induced cardiac dysfunction in cholestatic bile duct-ligated mice: Interaction between TNFα and endocannabinoids. J Hepatol 2010; 53:298-306.